Yazici, Duygu
Ogulur, Ismail
Kucukkase, Ozan
Li, Manru
Rinaldi, Arturo O.
Pat, Yagiz
Wallimann, Alexandra
Wawrocki, Sebastian
Celebi Sozener, Zeynep
Buyuktiryaki, Betul
Sackesen, Cansin
Akdis, Mubeccel
Mitamura, Yasutaka
Akdis, Cezmi A.
Funding for this research was provided by:
University of Zurich
Article History
Received: 10 March 2022
Accepted: 19 April 2022
First Online: 4 May 2022
Conflict of interest
: C.A. Akdis has received research grants from the Swiss National Science Foundation, Christine Kühne-Center for Allergy Research and Education, European Commission Horizon’s 2020 Framework Programme “CURE”, Novartis Research Institutes, GlaxoSmithKline and AstraZeneca. He took part in the advisory board and received research grants from GlaxoSmithKline, Sanofi/Regeneron, SciBase and Novartis. He is the Editor-in-Chief of <i>Allergy</i>. D. Yazici, I. Ogulur, O. Kucukkase, M. Li, A.O. Rinaldi, Y. Pat, A. Wallimann, S. Wawrocki, Z. Celebi Sozener, B. Buyuktiryaki, C. Sackesen, M. Akdis and Y. Mitamura declare that they have no competing interests.